Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 2014

View Archived Issues

UC MSCs show potential in clinical study for SLE

Roche updates pipeline developments of second quarter 2014

Medigen Biotechnology reports data from interim analysis of the phase III trial Patron

Study of BTT-1023 in primary sclerosing cholangitis awarded external grant funding

AstraZeneca and Qiagen to develop test for patients suitable for Iressa treatment

Lion Biotechnologies signs license agreement with Moffitt for TIL production technologies

AstraZeneca and Roche to develop companion diagnostic test for AZD-9291

Retroscreen Virology conducts hVIVO human challenge model study of Al-8176 in RSV

BiOasis' siRNA-Transcendpep reduces target gene expression in brain

Akers signs feasibility deal with Konica Minolta to develop cardiac muscle tissue damage test

Advanced Biological Laboratories and Roche Diagnostics renew and extend collaboration

KaloBios regains rights to KB-001A and updates on pipeline progress

AbbVie reviews pipeline activities of second quarter 2014

EMA committee recommends approval of Baraclude for pediatric patients with HBV

PoC viral gene therapy to rescue disease phenotype in tachycardiac mice

European Commission approves Eliquis for deep vein thrombosis and pulmonary embolism

Rationale for host-directed immunotherapy to treat M. tuberculosis infection

Cardioxyl advances CXL-1427 for decompensated heart failure after promising phase I trial

Targacept discontinues TC-5214 for overactive bladder

Rempex Pharmaceuticals discloses new beta-lactamase inhibitors

Roche's Gazyvaro approved in Europe for chronic lymphocytic leukemia

Korean researchers prepare new TGM2 inhibitors

New radiopharmaceutical metal complexes reported by Molecular InSight Pharmaceuticals

Incyte patents novel PIM kinase inhibitors

Novartis patent describes salts of DGAT1 inhibitor

FDA approves IND for ProHema in children with inherited metabolic disorders

FDA approves Eylea for diabetic macular edema

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...